The Order Of Preference Assessment Method Matters

Published Jul 17, 2012

South Bend, IN, USA – Cost-utility analysis is a common method for economic evaluation used to compare health care interventions. Standard gamble and time trade-off are two methods often both used for assessing the strength of an individual’s preferences (utility values) needed in such studies.

A recent study, “The Utility Assessment Method Order Influences Measurement of Parents’ Risk Attitude”, published in Value in Health used data from more than 4000 parent interviews to determine whether the order in which the two methods are applied impacts the measured preference. The study was co-authored by Drs. Maria Finnell, Aaron Carroll and Stephen Downs at the Indiana University School of Medicine.

Dr. Finnell says, “Our study shows that the order in which the standard gamble versus time trade-off method is used strongly influences the relative values of the measured preferences from parents. Our respondents, for example, appeared to be more willing to take risks to avoid a particular condition if the standard gamble method was applied first. Researchers should be aware of this impact on the measurements when comparing results from different studies. Whether there is a right or wrong order to use these two methods is yet to be determined.”

Value in Health (ISSN 1098-3015) publishes papers, concepts, and ideas that advance the field of pharmacoeconomics and outcomes research as well as policy papers to help health care leaders make evidence-based decisions. The journal is published bi-monthly and has over 8,000 subscribers (clinicians, decision makers, and researchers worldwide).

International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is a nonprofit, international, educational and scientific organization that strives to increase the efficiency, effectiveness, and fairness of health care resource use to improve health. For more information: www.ispor.org

Related Stories

New Research Collection Reveals How Artificial Intelligence Is Reshaping Health Economics

Nov 6, 2025

The PhRMA Foundation and ISPOR announced the publication of a special themed section of research papers that explores the dynamic intersection of artificial intelligence (AI) and health economics and outcomes research (HEOR).

ISPOR Announces 2025 Health Economics and Outcomes Research Award Honorees

Oct 20, 2025

ISPOR announced the recipients of its 2025 Health Economics and Outcomes Research (HEOR) Scientific and Leadership Awards. ISPOR Scientific Awards are designed to foster and recognize excellence and outstanding achievement in HEOR and its Leadership Awards recognize excellence and outstanding leadership in the field.

The Ozempic Paradox: How Spending Billions on Weight-Loss Drug Would Actually Reduce Overall Medicare Costs

Oct 14, 2025

Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced today the publication of a landmark study by researchers at the University of Washington, Curta, Inc, and the University of North Carolina showing that broad Medicare coverage of semaglutide in diabetes, obesity, and liver disease could generate significant cost savings while delivering substantial health benefits to beneficiaries. The report, “Comprehensive Access to Semaglutide: Clinical and Economic Implications for Medicare,” was published in the October 2025 issue of Value in Health.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×